For the year ending 2025-12-31, BCPC had $25,055K increase in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net earnings | 154,845 |
| Depreciation and amortization | 45,690 |
| Stock compensation expense | 18,057 |
| Deferred income taxes | 6,262 |
| (recovery of) provision for credit losses | -97 |
| Unrealized gain on foreign currency transactions and deferred compensation | -680 |
| Asset impairment charge and (gain) loss on disposal of assets | 58 |
| Change in fair value of contingent consideration liability | 0 |
| Accounts receivable | 20,853 |
| Inventories | -3,635 |
| Prepaid expenses and other current assets | 1,332 |
| Accounts payable and accrued expenses | 11,292 |
| Income taxes | -1,070 |
| Other | 865 |
| Net cash provided by operating activities | 216,556 |
| Capital expenditures and intangible assets acquired | 43,489 |
| Cash paid for acquisitions, net of cash acquired | 323 |
| Proceeds from sale of assets | 274 |
| Proceeds from settlement of net investment hedge | 0 |
| Investment in affiliates | 353 |
| Net cash used in investing activities | -43,891 |
| Proceeds from revolving loan | 88,000 |
| Principal payments on revolving debt | 114,000 |
| Principal payments on finance lease | 194 |
| Proceeds from stock options exercised | 9,307 |
| Dividends paid | 28,287 |
| Repurchases of common stock | 107,636 |
| Net cash used in financing activities | -152,810 |
| Effect of exchange rate changes on cash | 5,200 |
| Increase (decrease) in cash and cash equivalents | 25,055 |
| Cash and cash equivalents beginning of period | 49,515 |
| Cash and cash equivalents end of period | 74,570 |
BALCHEM CORP (BCPC)
BALCHEM CORP (BCPC)